Pfizer (HAM:PFE) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 24, 2026)


HAM:PFE Pfizer Inc HAM:PFE
74 GF Score
Price €21.83
GF Value €23.01
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Pfizer's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

HAM:PFE vs GILD, BMY, AMGN: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Pfizer's Margin of Safety % (DCF Earnings Based) falls into.


HAM:PFE
74GF Score
Pfizer Inc HAM:PFE
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pfizer (HAM:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of €21.83 is trading 5.1% below its estimated GF Value™ of €23.01. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for HAM:PFE:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €23.01 vs. price of €21.83 (5.1% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the HAM:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
74GF Score

Get the complete analysis for HAM:PFE

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.83
Price
€23.01
GF Value